Cargando…
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
BACKGROUND: It has been suggested that a small population of cells with unique self-renewal properties and malignant potential exists in solid tumors. Such "cancer stem cells" have been isolated by flow cytometry, followed by xenograft studies of their tumor-initiating properties. A freque...
Autores principales: | Immervoll, Heike, Hoem, Dag, Sakariassen, Per Øystein, Steffensen, Ole Johnny, Molven, Anders |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268945/ https://www.ncbi.nlm.nih.gov/pubmed/18261235 http://dx.doi.org/10.1186/1471-2407-8-48 |
Ejemplares similares
-
Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival
por: El Jellas, Khadija, et al.
Publicado: (2017) -
Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma
por: Choi, Man Hung, et al.
Publicado: (2019) -
Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers
por: Calatayud, Dan, et al.
Publicado: (2017) -
Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017) -
Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)